Eric Bishop, Vice President, R&D, Cygnus Technologies
Advertisement
Articles by Eric Bishop, Vice President, R&D, Cygnus Technologies
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Genmab’s Petosemtamab Plus Pembrolizumab Cuts Risk of Death by 50% in Phase 3 Head and Neck Cancer Trial
2
The BioPharm Brief: A Survival Win, a Myeloma Filing, and Gene Therapy for Swallowing
3
3SBio and Pfizer’s PD-1×VEGF Bispecific Shows Durable PFS Gains in First-Line NSCLC
4
Iovance’s Lifileucel Reaches 52% Response Rate in Biomarker-Selected Lung Cancer Subgroup
5